{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:33:59Z","timestamp":1790253239358,"version":"4.1.0"},"reference-count":75,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Diabetes mellitus is associated with morbid complications such as diabetic foot ulcers (DFUs) that may lead to amputations or mortality if not managed adequately.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>New adjunctive interventions to treat diabetic wounds include topical biologics and growth factors. This study aims to evaluate their efficacy in improving wound-healing outcomes and safety.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Comprehensive database searches of MEDLINE via PubMed, EMBASE, and Cochrane were performed from inception to December 2022. Three independent researchers selected the studies. Randomized controlled trials that compared the use of a topical biologic growth factor-containing regimen to other biologics or standard of care (SOC) were included. This review followed PRISMA guidelines. Risk of bias analysis was performed using the Jadad scale. Network meta-analysis was performed. Treatments were grouped into common nodes based on the type of biologic agent. Primary outcomes of interest were healing rate and time to wound closure. Secondary outcomes included wound infection, serious adverse events (AEs), and amputation rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Human umbilical cord (HUC) was associated with the highest cure, followed by recombinant human epidermal growth factor (hEGF). A significantly greater reduction in the time to cure DFUs was seen in HUC, hEGF, and fibroblast growth factor (FGF). There was a significantly lower risk of AEs when platelet-rich plasma (PRP) was administered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>HUC, hEGF, and FGF are promising topical biologics with statistically significant primary outcomes compared to SOC, while PRP is effective in reducing ulcer-related AEs. HUC has been found to be the most effective in terms of cure rate and a reduction in time to cure.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae128","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:34:00Z","timestamp":1710340440000},"page":"e1642-e1651","source":"Crossref","is-referenced-by-count":32,"title":["Improving Diabetic Wound-Healing Outcomes With Topical Growth Factor Therapies"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8667-0334","authenticated-orcid":false,"given":"Andrew Yew Wei","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore 119228 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Ming Foong","family":"Hooi","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University , Singapore 308232 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Sheng Yep","family":"Yeo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore 119228 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehena","family":"Sultana","sequence":"additional","affiliation":[{"name":"Duke-NUS Medical School, National University of Singapore , Singapore 169857 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Mong","family":"Bee","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Singapore General Hospital , Singapore 169608 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5896-2929","authenticated-orcid":false,"given":"Ainsley Ryan Yan Bin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore 119228 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-9470","authenticated-orcid":false,"given":"Sook Muay","family":"Tay","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore 119228 , Singapore"},{"name":"Department of Surgical Intensive Care, Singapore General Hospital , Singapore 169608 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"issue":"2_suppl","key":"2024071216424274000_dgae128-B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2047487319881021","article-title":"The global epidemics of diabetes in the 21st century: current situation and perspectives","volume":"26","author":"Standl","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"2024071216424274000_dgae128-B2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, Epidemiology, and disparities in the burden of diabetic foot ulcers","volume":"46","author":"McDermott","year":"2022","journal-title":"Diabetes Care"},{"key":"2024071216424274000_dgae128-B3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcot.2021.01.017","article-title":"The current burden of diabetic foot disease","volume":"17","author":"Edmonds","year":"2021","journal-title":"J Clin Orthop Trauma"},{"issue":"1","key":"2024071216424274000_dgae128-B4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/nyas.13569","article-title":"Update on management of diabetic foot ulcers","volume":"1411","author":"Everett","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2024071216424274000_dgae128-B5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1302\/2058-5241.3.180010","article-title":"Current concepts for the evaluation and management of diabetic foot ulcers","volume":"3","author":"Mavrogenis","year":"2018","journal-title":"EFORT Open Rev"},{"issue":"1","key":"2024071216424274000_dgae128-B6","doi-asserted-by":"crossref","first-page":"18545","DOI":"10.1038\/s41598-020-75584-7","article-title":"Fibroblast growth factor 2 accelerates the epithelial\u2013mesenchymal transition in keratinocytes during wound healing process","volume":"10","author":"Koike","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"2024071216424274000_dgae128-B7","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3390\/cells10071830","article-title":"Cellular mechanisms of FGF-stimulated tissue repair","volume":"10","author":"Prudovsky","year":"2021","journal-title":"Cells"},{"issue":"3","key":"2024071216424274000_dgae128-B8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1479-666X(08)80114-X","article-title":"Epidermal growth factor therapy and wound healing\u2013past, present and future perspectives","volume":"6","author":"Hardwicke","year":"2008","journal-title":"Surgeon"},{"issue":"1","key":"2024071216424274000_dgae128-B9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/wound.2011.0326","article-title":"Epidermal growth factor and epidermal growth factor receptor: the yin and yang in the treatment of cutaneous wounds and cancer","volume":"2","author":"Bodnar","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"2024071216424274000_dgae128-B10","doi-asserted-by":"crossref","first-page":"744868","DOI":"10.3389\/fendo.2021.744868","article-title":"Fibroblast growth factor in diabetic foot ulcer: progress and therapeutic prospects","volume":"12","author":"Liu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2024071216424274000_dgae128-B11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.JAA.0000464276.44117.b1","article-title":"Pathogenesis and management of diabetic foot ulcers","volume":"28","author":"Aumiller","year":"2015","journal-title":"JAAPA"},{"issue":"7","key":"2024071216424274000_dgae128-B12","first-page":"e27180","article-title":"Topical biological agents as adjuncts to improve wound healing in chronic diabetic wounds: a systematic review of clinical evidence and future directions","volume":"14","author":"Wong","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"2024071216424274000_dgae128-B13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40139-020-00215-9","article-title":"Beyond growth factors: macrophage-centric strategies for angiogenesis","volume":"8","author":"Nolfi","year":"2020","journal-title":"Curr Pathobiol Rep"},{"issue":"9","key":"2024071216424274000_dgae128-B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/mi11090815","article-title":"Characterization of diabetic and non-diabetic foot ulcers using single-cell RNA-sequencing","volume":"11","author":"Januszyk","year":"2020","journal-title":"Micromachines (Basel)"},{"issue":"7","key":"2024071216424274000_dgae128-B15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00125-002-0868-8","article-title":"Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients","volume":"45","author":"Lobmann","year":"2002","journal-title":"Diabetologia"},{"key":"2024071216424274000_dgae128-B16","doi-asserted-by":"crossref","first-page":"102610","DOI":"10.1016\/j.autneu.2019.102610","article-title":"Autonomic nerve dysfunction and impaired diabetic wound healing: the role of neuropeptides","volume":"223","author":"Theocharidis","year":"2020","journal-title":"Auton Neurosci"},{"issue":"14","key":"2024071216424274000_dgae128-B17","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/ijerph16142584","article-title":"Epidermal growth factor is effective in the treatment of diabetic foot ulcers: meta-analysis and systematic review","volume":"16","author":"Bui","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2024071216424274000_dgae128-B18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.avsg.2019.05.041","article-title":"Topical recombinant human epidermal growth factor for diabetic foot ulcers: a meta-analysis of randomized controlled clinical trials","volume":"62","author":"Yang","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"2024071216424274000_dgae128-B19"},{"issue":"11","key":"2024071216424274000_dgae128-B20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"2024071216424274000_dgae128-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"7650","key":"2024071216424274000_dgae128-B22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"2024071216424274000_dgae128-B23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"5 Pt 1","key":"2024071216424274000_dgae128-B24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00129334-200506000-00012","article-title":"Randomized clinical trial comparing OASIS wound matrix to regranex gel for diabetic ulcers","volume":"18","author":"Niezgoda","year":"2005","journal-title":"Adv Skin Wound Care"},{"issue":"5","key":"2024071216424274000_dgae128-B25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2337\/diacare.21.5.822","article-title":"Efficacy and safely of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study","volume":"21","author":"Wieman","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"2024071216424274000_dgae128-B26","first-page":"83","article-title":"Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial","volume":"27","author":"Ma","year":"2015","journal-title":"Wounds"},{"key":"2024071216424274000_dgae128-B27","doi-asserted-by":"crossref","first-page":"109775","DOI":"10.1016\/j.diabres.2022.109775","article-title":"Comparing the standard surgical dressing with dehydrated amnion and platelet-derived growth factor dressings in the healing rate of diabetic foot ulcer: a randomized clinical trial","volume":"185","author":"Mohammadi Tofigh","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2024071216424274000_dgae128-B28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/cer-2019-0142","article-title":"A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers","volume":"9","author":"Serena","year":"2020","journal-title":"J Comp Eff Res"},{"issue":"6","key":"2024071216424274000_dgae128-B29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/iwj.12954","article-title":"Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients","volume":"15","author":"DiDomenico","year":"2018","journal-title":"Int Wound J"},{"issue":"8","key":"2024071216424274000_dgae128-B30","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1097\/GOX.0000000000002371","article-title":"Placental membrane provides improved healing efficacy and lower cost versus a tissue-engineered human skin in the treatment of diabetic foot ulcerations","volume":"7","author":"Glat","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"6","key":"2024071216424274000_dgae128-B31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/iwj.12395","article-title":"A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion\/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers","volume":"12","author":"Zelen","year":"2015","journal-title":"Int Wound J"},{"issue":"3","key":"2024071216424274000_dgae128-B32","first-page":"70","article-title":"A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer","volume":"28","author":"Snyder","year":"2016","journal-title":"Wounds"},{"issue":"1","key":"2024071216424274000_dgae128-B33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/iwj.12976","article-title":"A confirmatory study on the efficacy of dehydrated human amnion\/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics","volume":"16","author":"Tettelbach","year":"2019","journal-title":"Int Wound J"},{"issue":"1","key":"2024071216424274000_dgae128-B34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/iwj.13001","article-title":"A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers","volume":"16","author":"Tettelbach","year":"2019","journal-title":"Int Wound J"},{"issue":"5","key":"2024071216424274000_dgae128-B35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/iwj.13571","article-title":"The effectiveness of a new dried human amnion derived membrane in addition to standard care in treating diabetic foot ulcers: a patient and assessor blind, randomised controlled pilot study","volume":"18","author":"Game","year":". 2021","journal-title":"Int Wound J"},{"issue":"13","key":"2024071216424274000_dgae128-B36","first-page":"5987","article-title":"Observation of curative effect of recombinant human basic fibroblast growth factor combined with compound polymyxin B ointment and local application of insulin on wound healing of deep second-degree burn in diabetes mellitus: a randomized study","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"2024071216424274000_dgae128-B37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2009.0750","article-title":"Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer","volume":"19","author":"Uchi","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"1","key":"2024071216424274000_dgae128-B38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diacare.18.1.64","article-title":"Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study","volume":"18","author":"Richard","year":"1995","journal-title":"Diabetes Care"},{"key":"2024071216424274000_dgae128-B39","author":"Olympus Biotech"},{"key":"2024071216424274000_dgae128-B40","author":"Olympus Biotech"},{"issue":"6","key":"2024071216424274000_dgae128-B41","first-page":"5365","article-title":"Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds","volume":"15","author":"Xu","year":"2018","journal-title":"Exp Ther Med"},{"issue":"6","key":"2024071216424274000_dgae128-B42","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","article-title":"Human epidermal growth factor enhances healing of diabetic foot ulcers","volume":"26","author":"Tsang","year":"2003","journal-title":"Diabetes Care"},{"issue":"5","key":"2024071216424274000_dgae128-B43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2217\/14750708.2.5.759","article-title":"Efficacy of topical epidermal growth factor in healing diabetic foot ulcers","volume":"2","author":"Afshari","year":"2005","journal-title":"Therapy"},{"issue":"2","key":"2024071216424274000_dgae128-B44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1534734619892791","article-title":"Efficacy of recombinant human epidermal growth factor (regen-D 150) in healing diabetic foot ulcers: a hospital-based randomized controlled trial","volume":"19","author":"Viswanathan","year":"2020","journal-title":"Int J Low Extrem Wounds"},{"issue":"2","key":"2024071216424274000_dgae128-B45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0976-9668.136160","article-title":"Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's grade 1 and 2 diabetic foot ulcers: comparative analysis of 50 patients","volume":"5","author":"Garg","year":"2014","journal-title":"J Nat Sci Biol Med"},{"issue":"1","key":"2024071216424274000_dgae128-B46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12968\/jowc.2008.17.1.27917","article-title":"Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers","volume":"17","author":"Hanft","year":"2008","journal-title":"J Wound Care"},{"issue":"6","key":"2024071216424274000_dgae128-B47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/wrr.12969","article-title":"Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing: pilot, double-blind, randomized clinical controlled trial","volume":"29","author":"Oliveira","year":"2021","journal-title":"Wound Repair Regen"},{"key":"2024071216424274000_dgae128-B48","doi-asserted-by":"crossref","first-page":"627098","DOI":"10.3389\/fphar.2021.627098","article-title":"Therapeutic effect of epidermal growth factor combined with nano silver dressing on diabetic foot patients","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"2024071216424274000_dgae128-B49","first-page":"52","article-title":"Evaluation of the efficacy and safety of topical epidermal growth factor regen-D\u00ae in diabetic foot wounds: a randomised, parallel group phase III study","volume":"24","author":"Aktas","year":"2021","journal-title":"Diabetic Foot J"},{"key":"2024071216424274000_dgae128-B50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.avsg.2016.04.023","article-title":"Platelet-Rich plasma for the treatment of clean diabetic foot ulcers","volume":"38","author":"Ahmed","year":"2017","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"2024071216424274000_dgae128-B51","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00268-019-05316-0","article-title":"Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers","volume":"44","author":"Elsaid","year":"2020","journal-title":"World J Surg"},{"issue":"4","key":"2024071216424274000_dgae128-B52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/wrr.12294","article-title":"Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: a prospective, randomized clinical trial","volume":"23","author":"Li","year":"2015","journal-title":"Wound Repair Regen"},{"issue":"6","key":"2024071216424274000_dgae128-B53","first-page":"68","article-title":"A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","author":"Driver","year":"2006","journal-title":"Ostomy Wound Manage"},{"issue":"6","key":"2024071216424274000_dgae128-B54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0939-4753(04)80029-2","article-title":"A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers","volume":"14","author":"Saldalamacchia","year":"2004","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"2024071216424274000_dgae128-B55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jdiacomp.2007.03.006","article-title":"Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial","volume":"21","author":"Kakagia","year":"2007","journal-title":"J Diabetes Complications"},{"issue":"2","key":"2024071216424274000_dgae128-B56","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.dsx.2021.03.005","article-title":"Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: a randomized clinical trial in Tehran, Iran","volume":"15","author":"Malekpour Alamdari","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"2024071216424274000_dgae128-B57","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.wndm.2020.100178","article-title":"The efficacy of platelet gel derived from umbilical cord blood on diabetic foot ulcers: a double-blind randomized clinical trial","volume":"28","author":"Hosseini","year":"2020","journal-title":"Wound Med"},{"key":"2024071216424274000_dgae128-B58","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.avsg.2022.07.026","article-title":"The efficacy of autologous platelet-rich gel and traditional Chinese medicine in diabetic foot treatment: a parallel randomized controlled clinical trial","volume":"87","author":"Du","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"2024071216424274000_dgae128-B59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2231-0738.184583","article-title":"Foot care education and platelet derived growth factor on wound healing in foot ulcers among adults","volume":"6","author":"D'Souza","year":"2016","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"issue":"1","key":"2024071216424274000_dgae128-B60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"2024071216424274000_dgae128-B61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/wrr.12754","article-title":"An open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis","volume":"27","author":"Marston","year":"2019","journal-title":"Wound Repair Regen"},{"issue":"1","key":"2024071216424274000_dgae128-B62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0094-1298(02)00066-4","article-title":"Wound healing and diabetes mellitus","volume":"30","author":"Greenhalgh","year":"2003","journal-title":"Clin Plast Surg"},{"key":"2024071216424274000_dgae128-B63","first-page":"11","article-title":"Safety and efficacy of becaplermin gel in the treatment of diabetic foot ulcers","volume":"1","author":"Blume","year":"2014","journal-title":"Chronic Wound Care Manag Res"},{"issue":"3","key":"2024071216424274000_dgae128-B64","first-page":"373","article-title":"Prevention of diabetic foot ulcer","volume":"4","author":"Iraj","year":"2013","journal-title":"Int J Prev Med"},{"issue":"9498","key":"2024071216424274000_dgae128-B65","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"2024071216424274000_dgae128-B66","author":"Tissue Tech Inc."},{"key":"2024071216424274000_dgae128-B67","author":"Tissue Tech Inc"},{"key":"2024071216424274000_dgae128-B68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.avsg.2021.10.061","article-title":"Autologous platelet rich plasma promotes the healing of non-ischemic diabetic foot ulcers. A randomized controlled trial","volume":"82","author":"Hossam","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"2024071216424274000_dgae128-B69"},{"issue":"1","key":"2024071216424274000_dgae128-B70","doi-asserted-by":"crossref","first-page":"1480249","DOI":"10.1080\/2000625X.2018.1480249","article-title":"Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers","volume":"9","author":"Romero Prada","year":"2018","journal-title":"Diabet Foot Ankle"},{"key":"2024071216424274000_dgae128-B71"},{"issue":"Suppl 1","key":"2024071216424274000_dgae128-B72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1524-4733.2000.36027.x","article-title":"The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (regranex): a core model with an application using Swedish cost data","volume":"3","author":"Persson","year":"2000","journal-title":"Value Health"},{"issue":"1","key":"2024071216424274000_dgae128-B73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1472-6963-9-115","article-title":"Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers","volume":"9","author":"Langer","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"2024071216424274000_dgae128-B74"},{"issue":"1","key":"2024071216424274000_dgae128-B75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13300-018-0536-8","article-title":"Reasonable glycemic control would help wound healing during the treatment of diabetic foot ulcers","volume":"10","author":"Xiang","year":"2019","journal-title":"Diabetes Ther"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae128\/57060683\/dgae128.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/8\/e1642\/58530528\/dgae128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/8\/e1642\/58530528\/dgae128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:45:20Z","timestamp":1720802720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/8\/e1642\/7627888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,3,13]]},"published-print":{"date-parts":[[2024,7,12]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae128","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,3,13]]}}}